Quincy Bioscience’s Prevagen

In July 2019, a class-action lawsuit was filed against Quincy Bioscience for allegedly falsely advertising that the dietary supplement Prevagen improves memory within 90 days and supports “Healthy Brain Function,” “Sharper Mind,” and “Clearer Thinking” when, according to plaintiffs, the supplement does not provide the advertised benefits. (Plaintiffs filed an amended complaint bringing similar allegations in September 2019.) (Collins et al v. Quincy Bioscience, LLC, Case No. 19-cv-22864, S. D. FL.)

For more of TINA.org’s coverage of Prevagen, click here.

Print Friendly, PDF & Email

Tags: , ,



Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker



  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect TINA.org’s opinion with respect to the lawsuits or disposition of the cases

  • Sign Up for E-mail Updates